---
schema_version: "secwatch.filing_event.v1"
accession: "0000898432-24-000125"
form_type: "8-K"
ticker: "OSRH"
cik: "0001840425"
company_name: "OSR Holdings, Inc."
filed_at: "2024-02-13T23:59:59+00:00"
generated_at: "2026-06-06T03:41:02.442857+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Bellevue Life Sciences extends business combination deadline to May 14; issues $75K promissory note to director

## Summary
- Charter amendment extends business combination deadline from Feb 14, 2024 to May 14, 2024.
- $75,000 unsecured promissory note issued to director Jun Chul Whang, due Aug 9, 2024 or at business combination, with no interest.
- $60,000 deposited into trust account for one-month extension from Feb 14 to Mar 14, 2024.
- Note principal forgiven if company fails to complete business combination by extended deadline.

## SEC filing metadata
- accession: 0000898432-24-000125
- form_type: 8-K
- ticker: OSRH
- cik: 0001840425
- company_name: OSR Holdings, Inc.
- filed_at: 2024-02-13T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 2.03, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840425/000089843224000125/0000898432-24-000125-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840425/000089843224000125/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000898432-24-000125
- JSON: https://secwatch.observer/filing/0000898432-24-000125.json
- Plain text: https://secwatch.observer/filing/0000898432-24-000125.txt

## Key facts
- Debt Financings
  OSR Holdings, Inc. incurred loan of $75,000 with Jun Chul Whang at not interest bearing maturing the earlier of: (i) August 9, 2024 or (ii) the date on which the Company consummates an initial business combination.
  - Instrument: loan
  - Principal: $75,000
  - Counterparty: Jun Chul Whang
  - Rate: not interest bearing
  - Maturity: the earlier of: (i) August 9, 2024 or (ii) the date on which the Company consummates an initial business combination
  - Event: incurrence
  source text: On February 9, 2024, Bellevue Life Sciences Acquisition Corp. (the “ Company ”) issued an unsecured promissory note (the “ Promissory Note ”) in the principal amount of $75,000 to Jun Chul Whang, a member of the Company’s Board of Directors (the “ Board ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1840425/000089843224000125/0000898432-24-000125-index.htm
- Governance Changes
  OSR Holdings, Inc.: Stockholders approved a proposal to allow the Board to amend the Certificate of Incorporation to extend the deadline for consummating a business combination from February 14, 2024 to May 14, 2024 (effective 2024-02-09).
  - Change: charter amendment
  - Effective: 2024-02-09
  source text: At the special meeting of the Company’s stockholders held on November 9, 2023, the stockholders approved a proposal to give the Board the authority, in its discretion, to amend the Company’s Certificate of Incorporation (the “ Charter ”) to extend the date by which the Company must consummate a business combination from the February 14, 2024 to May 14, 2024. The Board authorized and approved a Certificate of Amendment to the Company’s Charter (the “ Charter Amendment ”) and the Charter Amendment was filed with the Delaware Secretary of State and has an effective date of February 9, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1840425/000089843224000125/0000898432-24-000125-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.